April 7th 2020: Spotlight on Coronavirus: Your Questions Answered Part 2 |eCard

TROUBLE VIEWING? Click Here to view the Promo card on the web

SIGN-UP NOW! Click to become a Member for Free!

Frankly Speaking About Cancer with the Cancer Support Community

Tuesdays at 1 PM Pacific

April 7th 2020: Spotlight on Coronavirus: Your Questions Answered Part 2

In this installment of our special series Spotlight on Coronavirus, we’ll be addressing questions and concerns raised in the Cancer Support Community’s Research and Training Institute’s recently launched survey asking cancer patients and their caregivers to identify their concerns about the spread of coronavirus. Returning to the show is Dr. Merry Jennifer Markham and joining us for the first time is Dr. William Dahut. The Cancer Support Community provides the content in this program for informational purposes only. The information does not constitute medical or legal advice and is not in

Read more

DOWNLOAD PDF

Tune in

Tuesdays at 1 PM Pacific Time on VoiceAmerica Health and Wellness Channel

LISTEN LIVE

EPISODE ON DEMAND

VIEW HOST PAGE

Questions? Comments?
Call In Live! Call-In
Toll Free: 1-866-472-5792
Intl: 001-480-553-5759

Featured Guests

Merry Jennifer Markham

Dr. Merry Jennifer Markham is associate professor and interim chief of the Division of Hematology and Oncology at the University of Florida (UF). She is associate director for Medical Affairs for the University of Florida Health Cancer Center, and she is a medical oncologist specializing in gynecologic cancers. She is chair of the ASCO Cancer Communications Committee and is the social media editor for the Journal of Clinical Oncology and the Journal of the National Cancer Institute.

Read more

William Dahut

Dr. Dahut is the Scientific Director for Clinical Research at the National Cancer Institute’s Center for Cancer Research (CCR). In this role, Dr. Dahut oversees and assures the quality of medical care delivered to patients participating in CCR clinical trials. Dr. Dahut is also the Section Chief of the clinical/translational prostate cancer research program, which emphasizes new approaches to the treatment, diagnosis and prognostic evaluation of prostate cancer with the goal to increase the precision in which therapeutic decisions are made for patients with primary and metastatic prostate cancer. In this research, his mission is to improve therapy for men with advanced prostate cancer.

Read more

Share This Episode

Share On Facebook

Share On Twitter

Share On LinkedIn

Connect with VoiceAmerica

Download our mobile apps